Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


1 Am J Hematol
1 Blood
1 Br J Dermatol
2 Br J Haematol
2 Haematologica
1 Hum Pathol
2 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Am Acad Dermatol
2 J Clin Oncol
2 Lancet Oncol
4 Leuk Lymphoma
1 Oncol Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Hematol

  1. POPHALI PA, Ip A, Larson MC, Rosenthal AC, et al
    The Association of Physical Activity Before and After Lymphoma Diagnosis with Survival Outcomes.
    Am J Hematol. 2018 Sep 19. doi: 10.1002/ajh.25288.
    PubMed     Text format     Abstract available


  2. ELSHIEKH M, Naresh KN
    A rare case of renal intravascular NK/T-cell lymphoma.
    Blood. 2018;132:1354.
    PubMed     Text format    

    Br J Dermatol

  3. KEMPF W
    Multifocal anaplastic large cell lymphoma - insight into its biology and treatment.
    Br J Dermatol. 2018;179:565-566.
    PubMed     Text format    

    Br J Haematol

  4. BROCKELMANN PJ, McMullen S, Wilson JB, Mueller K, et al
    Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom.
    Br J Haematol. 2018 Sep 21. doi: 10.1111/bjh.15566.
    PubMed     Text format     Abstract available

  5. Sixth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma Abstracts, 26-29 September 2018, De Doelen International Congress Centre, Rotterdam, Netherlands.
    Br J Haematol. 2018;182 Suppl 1:5-109.
    PubMed     Text format    


  6. LEIVONEN SK, Pollari M, Bruck O, Pellinen T, et al
    T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma.
    Haematologica. 2018 Sep 20. pii: haematol.2018.200105.
    PubMed     Text format     Abstract available

  7. OCHI Y, Hiramoto N, Yoshizato T, Ono Y, et al
    Clonally related diffuse large B-cell lymphoma and interdigitating dendritic cell sarcoma sharing MYC translocation.
    Haematologica. 2018 Sep 20. pii: haematol.2018.193490.
    PubMed     Text format    

    Hum Pathol

  8. LIU J, Liang L, Huang S, Nong L, et al
    Aberrant differential expression of EZH2 and H3K27me3 in extranodal NK/T-cell lymphoma, nasal type is associated with disease progression and prognosis.
    Hum Pathol. 2018 Sep 12. pii: S0046-8177(18)30351.
    PubMed     Text format     Abstract available

    Int J Cancer

  9. PURDUE MP, Lan Q, Hoffman-Bolton J, Hildesheim A, et al
    Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma risk.
    Int J Cancer. 2018 Sep 19. doi: 10.1002/ijc.31879.
    PubMed     Text format     Abstract available

  10. CHATTOPADHYAY S, Sud A, Zheng G, Yu H, et al
    Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.
    Int J Cancer. 2018 Sep 21. doi: 10.1002/ijc.31801.
    PubMed     Text format     Abstract available

    Int J Radiat Oncol Biol Phys

  11. DABAJA BS, Specht L, Yahalom J
    Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG).
    Int J Radiat Oncol Biol Phys. 2018;102:508-514.
    PubMed     Text format     Abstract available

    J Am Acad Dermatol

  12. LEE WJ, Won KH, Choi JW, Won CH, et al
    Cutaneous angioimmunoblastic T-cell lymphoma: Epstein-Barr Virus positivity and its effects on clinicopathological features.
    J Am Acad Dermatol. 2018 Sep 18. pii: S0190-9622(18)32586.
    PubMed     Text format     Abstract available

    J Clin Oncol

    Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphoma: Standard of Care After the PETAL Study?
    J Clin Oncol. 2018 Sep 17:JCO1800498. doi: 10.1200/JCO.18.00498.
    PubMed     Text format    

  14. ADAMS HJA, Kwee TC
    Unproven Clinical Value of Interim FDG-PET in Aggressive Non-Hodgkin Lymphoma.
    J Clin Oncol. 2018 Sep 17:JCO1800323. doi: 10.1200/JCO.18.00323.
    PubMed     Text format    

    Lancet Oncol

  15. LAMBERTINI M, Demeestere I
    Another step towards improving oncofertility counselling of young women with Hodgkin's lymphoma.
    Lancet Oncol. 2018 Sep 13. pii: S1470-2045(18)30562.
    PubMed     Text format    

  16. ANDERSON RA, Remedios R, Kirkwood AA, Patrick P, et al
    Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial.
    Lancet Oncol. 2018 Sep 13. pii: S1470-2045(18)30500.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  17. SHAO C, Liu J, Zhou W, Raut MK, et al
    Treatment patterns, health care resource utilization, and costs in patients with relapsed/refractory Hodgkin lymphoma treated with brentuximab vedotin.
    Leuk Lymphoma. 2018 Sep 20:1-8. doi: 10.1080/10428194.2018.1508665.
    PubMed     Text format     Abstract available

  18. CAMUS V, Dubois S, Jardin F, Tilly H, et al
    Prognostic impact of diagnosis to treatment interval (DTI) in diffuse large B-cell lymphoma patients: a real-life monocentric study.
    Leuk Lymphoma. 2018 Sep 20:1-3. doi: 10.1080/10428194.2018.1508671.
    PubMed     Text format    

  19. PROVENCIO M, Franco F, Gomez-Codina J, Quero Blanco C, et al
    Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years.
    Leuk Lymphoma. 2018 Sep 20:1-4. doi: 10.1080/10428194.2018.1509322.
    PubMed     Text format    

  20. CENCINI E, Fabbri A, Schiattone L, Bocchia M, et al
    Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphoma.
    Leuk Lymphoma. 2018 Sep 20:1-3. doi: 10.1080/10428194.2018.1504938.
    PubMed     Text format    

    Oncol Rep

  21. YAN W, Li SX, Wei M, Gao H, et al
    Identification of MMP9 as a novel key gene in mantle cell lymphoma based on bioinformatic analysis and design of cyclic peptides as MMP9 inhibitors based on molecular docking.
    Oncol Rep. 2018;40:2515-2524.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.